Has Charles Darragh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,702 in general payments to Charles Darragh, MD across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Darragh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Darragh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Darragh, MD

MOHS-Micrographic Surgery · Greenville, SCNPI 1245676774

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.2% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 38.7% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in SC, where the typical reported total is $2,794.

$1,702in general payments, 2019–2025

Across 78 payments — averaging $21.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$658
Organogenesis Inc.$316
Johnson & Johnson$129
Lilly USA, LLC$101
Novartis$73
Ortho Dermatologics, A Division Of Bausch Health US, LLC$62
plus $363 from 13 others

What the payments were for

Food & beverage$1,60394%
Education$996%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	30	$658
Organogenesis Inc.	13	$316
Johnson & Johnson	3	$129
Lilly USA, LLC	5	$101
Novartis	4	$73
Ortho Dermatologics, A Division Of Bausch Health US, LLC	4	$62
Sun Pharmaceutical Industries Inc.	2	$46
UCB, Inc.	2	$41
Incyte Corporation	2	$39
Genentech USA, Inc.	2	$37
E.r. Squibb & Sons, L.L.C.	2	$35
Amgen	2	$32
Merck	1	$24
LEO Pharma Inc.	1	$23
Botanix SB Inc	1	$23
Bristol Myers Squibb	1	$22
Paratek Pharmaceuticals, Inc.	1	$16
Promius Pharma LLC	1	$14
Mylan Pharmaceuticals Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Rinvoq$123

How this compares

$1,702 in reported general payments places this provider in the 40th percentile of 22 mohs-micrographic surgery providers in South Carolina.

See all mohs-micrographic surgery providers in South Carolina →

Medicare billing

Part B allowed, 2024

$952,120

Medicare patients

868

Services billed

4,420

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mupirocin	225	$1,360
Clobetasol Propionate	18	$1,225
Doxycycline Hyclate	119	$1,083
Ketoconazole	62	$699
Betamethasone Dipropionate	17	$545
Triamcinolone Acetonide	38	$496
Minocycline Hcl	13	$109
Doxycycline Monohydrate	11	$89
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	32	$73
Cephalexin	24	$48
Alprazolam	11	$4

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Greenville

Julie JeffersonGreenville$5K
Joel PhillipsGreenville$3K
Christopher PetersonGreenville$1K
Fabrizio GalimbertiConway$765K
Yumeng LiConway$33K
Brandon CoakleyMyrtle Beach$24K
Joseph McGowanBluffton$10K
Bradley SaylorsNorth Charleston$8K
Ruth McTigheMt Pleasant$7K
Taylor MulkeyMt Pleasant$7K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →